SAN FRANCISCO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman is notifying Ardent Health, Inc. (NYSE: ARDT) investors that a securities class action lawsuit has been filed against the company and certain of its executives following the company’s disastrous Q3 2025 financial results. Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves. The firm urges inves ...

New York, New York--(Newsfile Corp. - January 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of F5, Inc. (NASDAQ: FFIV) between October 28, 2024 and October 27, 2025, both dates inclusive (the "Class Period"), of the important February 17, 2026 lead plaintiff deadline.SO WHAT: If you purchased F5 securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Agilon Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1] Group 1: Class Action Details - The Class Period for the securities class action is from February 26, 2025, to August 4, 2025 [1] - Investors who purchased Agilon securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 2, 2026 [3] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4] Group 3: Case Allegations - The lawsuit alleges that defendants made false or misleading statements and failed to disclose critical information, including issuing unrealistic guidance for 2025 despite known industry challenges [5] - It is claimed that defendants overstated the financial impact of strategic actions taken by Agilon, leading to materially false statements about the company's business and prospects [5] - The lawsuit asserts that when the true information became public, investors suffered damages [5]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to alleged violations of federal securities laws, particularly concerning misleading statements and guidance regarding the company's financial performance [2][5]. Group 1: Legal Investigation and Claims - The law firm is encouraging investors who suffered losses in agilon health to contact them directly to discuss their legal options [1]. - A federal securities class action has been filed against agilon health, with a deadline of March 2, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that agilon health and its executives made false statements and failed to disclose significant industry challenges, leading to misleading guidance for 2025 [5]. Group 2: Financial Impact and Stock Performance - On August 4, 2025, agilon health announced the suspension of its previously issued full-year 2025 financial guidance, citing more acute industry headwinds than expected [6]. - Following this announcement, agilon health's stock experienced a significant decline of 51.5% on August 5, 2025 [6]. Group 3: Company Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Sprouts Farmers Market, Inc. due to allegations of misleading statements regarding the company's growth potential and sales performance [2][5]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Sprouts between June 4, 2025, and October 29, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Sprouts, with a deadline of January 26, 2026, for investors to seek the role of lead plaintiff [2]. Group 2: Allegations Against Sprouts - The complaint alleges that Sprouts and its executives violated federal securities laws by making false and misleading statements about the company's growth potential and failing to disclose material adverse facts [5]. - Specifically, the allegations include that the company provided overly positive statements while concealing the risk of a significant slowdown in sales growth due to a more cautious consumer [5]. Group 3: Financial Performance - On October 29, 2025, Sprouts reported a 4.3% decrease in comparable store growth compared to the previous quarter, which was below the company's prior projections [6]. - The company projected only 0%-2% growth in comparable sales for the fourth quarter and reduced its full-year expectations from 7.5%-9% to 7% [6]. - Following the announcement of these results, Sprouts' stock price fell by $22.64 per share, opening at $81.91 [6].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Bath & Body Works, Inc. due to alleged violations of federal securities laws, encouraging affected investors to contact them for legal options [2][4]. Financial Performance - Bath & Body Works reported a disappointing third quarter for 2025, with a 1% year-over-year decline in revenue, missing prior guidance of 1-3% growth, and a 26% drop in net income to $77 million [5]. - The company significantly reduced its full-year earnings per diluted share guidance from a range of $3.28 to $3.53 to "at least $2.83" [5]. Strategic Issues - The complaint alleges that the company's strategy of pursuing "adjacencies, collaborations and promotions" failed to grow the customer base and did not deliver the expected growth in net sales [4]. - The company admitted that its previous strategy led to reduced investment in core categories and an overreliance on promotions to mask weak financial results [5]. Stock Market Reaction - Following the disappointing financial disclosures, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share on November 20, 2025 [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of StubHub Holdings, Inc. about the upcoming lead plaintiff deadline for a class action lawsuit related to the company's September 2025 IPO [1]. Group 1: Class Action Details - Investors who purchased StubHub common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 23, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been recognized as a leader in the field [4]. Group 3: Case Allegations - The lawsuit claims that the Registration Statement was materially false and misleading, omitting critical information about changes in payment timing to vendors and its adverse impact on free cash flow [5]. - It is alleged that these omissions led to misleading reports on StubHub's free cash flow and that positive statements made by the defendants lacked a reasonable basis [5].

Core Viewpoint - A class action securities lawsuit has been filed against Coupang, Inc. for alleged securities fraud affecting investors between May 7, 2025, and December 16, 2025 [1][2]. Group 1: Allegations - The lawsuit claims that Coupang had inadequate cybersecurity protocols, allowing a former employee to access sensitive customer information for nearly six months without detection [2]. - It is alleged that this data breach exposed Coupang to increased regulatory and legal scrutiny [2]. - The defendants reportedly failed to disclose the data breach in a timely manner as required by SEC reporting rules, leading to materially false and misleading public statements [2]. Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until February 17, 2026, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3]. Group 3: Law Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4]. - The firm has over 70 employees dedicated to serving clients in complex securities litigation [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased F5, Inc. securities between October 28, 2024, and October 27, 2025, of the February 17, 2026, deadline to serve as lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought F5 securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by February 17, 2026, to serve as lead plaintiff, representing other class members [2]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [3]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 [3]. Group 3: Case Allegations - The lawsuit alleges that F5's management misled investors by presenting an overly optimistic revenue outlook and downplaying risks associated with seasonality and macroeconomic factors [4]. - It is claimed that F5 was experiencing a significant security incident that jeopardized its clients' security and the company's future prospects, leading to investor damages when the truth was revealed [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of StubHub Holdings, Inc. about the upcoming lead plaintiff deadline for a class action lawsuit related to the company's September 2025 IPO [1]. Group 1: Class Action Details - Investors who bought StubHub common stock may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 23, 2026 [3]. - The lawsuit claims that the Registration Statement was materially false and misleading, omitting significant information about changes in payment timing to vendors and its adverse impact on free cash flow [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action litigation [4].